University of Southampton researchers have played a key role in the trial of a potential new treatment for a severe eye disease – Acanthamoeba Keratitis (AK). Dr Parwez Hossain was involved in the study, which has now been published in the journal ‘Ophthalmology’: The Orphan Drug for Acanthamoeba Keratitis (ODAK) trial: PHMB (polihexanide) 0.08% and placebo versus PHMB 0.02% and propamidine 0.1% – ScienceDirect
